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Abstract 
ARHGAP21 is a Rho GTPase-activating protein 
(RhoGAP). Like other members of the RhoGAP 
family, ARHGAP21 enhances the intrinsic GTPase 
activity of small Rho GTPases, leading to their 
inactivation. ARHGAP21 participates in cellular 
proliferation, adhesion, migration and vesicle traffic. 
This review comprises information on DNA/RNA, 
the encoded protein and protein functions. 
Keywords: ARHGAP21; Rho GTPase-activating 
protein; RhoGAP; cellular proliferation; adhesion; 
migration; vesicle traffic; glioblastoma multiforme; 
prostate adenocarcinoma; ovarian cancer; breast 
cancer; head and neck squamous cell carcinoma. 
Identity 
Other names: ARHGAP10 
HGNC (Hugo): ARHGAP21 
Location: 10p12.1 - 10p12.3 
DNA/RNA 
Description 
The entire ARHGAP21 gene has approximately 
141,813 base pairs (bp) (Start: 24,583,609 and End: 
24,725,421; on the reverse strand) and is composed 
of 26 exons. The cDNA contains 5877 bp. 
Protein 
Description 
RhoGAPs are usually large proteins with additional 
domains other than the RhoGAP domain 
(Tcherkezian and Lamarche-Vane 2007). 
ARHGAP21 is composed of 1958 amino acids and 
has a predicted molecular weight of 217 kDa. In 
addition to the RhoGAP domain, ARHGAP21 
comprises a PH (pleckstrin homology) and a PDZ 
domain (Figure 1).  
Figure 1. Schematic representation of ARHGAP21 protein.  Domain positions were based on National Center for 
Biotechnology Information (NCBI) (https://www.ncbi.nlm.nih.gov/gene/57584). 
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Although PH domains can bind to 
phosphatidylinositol lipids within biological 
membranes (Harlan et al. 1994; Saito et al. 2001), the 
ARHGAP21 PH domain has been demonstrated to 
not bind to lipids (Dubois et al. 2005). ARHGAP21 
has been described to be SUMOylated in lysine 
K1443 by SUMO2/3. 
This post-translational modification may possibly 
explain the higher weight found by mass 
spectrometry (250 kDa) in contrast with the 
predicted weight (Bigarella et al. 2009). 
Expression 
ARHGAP21 gene was widely expressed in a panel 
of different human tissues. Higher ARHGAP21 gene 
expression was observed in brain, heart, skeletal 
muscle, and placenta (Basseres et al. 2002). Results 
from FANTOM5 project also showed an increased 
ARHGAP21 gene expression in tissues of the human 
nervous system, such as cerebellum, diencephalon 
and hippocampus (Expression Atlas data bank). 
Localisation 
ARHGAP21 has been shown to localize in the nuclei 
and cytoplasm of different cell types, such as 
adenocarcinoma PC3 and LNCAP cells and in 
glioblastoma T98G cells (Bigarella et al. 2009; 
Lazarini et al. 2013). In epithelial Caco-2 and JEG-3 
cells, ARHGAP21 was detected at the cell-cell 
junctions and at the nucleus and perinuclear region 
(Sousa et al. 2005). Breast adenocarcinoma MCF-7 
cells and HeLa cells presented ARHGAP21 
localization in Golgi complex and in vesicular 
cytoplasmic structures (Dubois et al. 2005). In 
cardiomyocytes, ARHGAP21 was relocated from 
the nucleus to Z-lines and costameres after pressure 
overload (Borges et al. 2008). 
Function 
ARHGAP21 acts as a RhoGAP for RHOA, RHOC 
andCDC42, but not for RAC1 (Dubois et al. 2005; 
Sousa et al. 2005; Lazarini et al. 2013). Such as 
occurs with other RhoGAP proteins, the 
ARHGAP21 RhoGAP activity has not been tested 
for most Rho GTPases. However, several 
ARHGAP21 partners have been described, 
suggesting that ARHGAP21 functions as a scaffold, 
linking Rho GTPases to other signaling pathways. 
ARHGAP21 has been shown to interact with ARF1, 
ARF6 (Dubois et al. 2005), catenin alpha (Sousa et 
al. 2005), PTK2 (FAK), PRKCZ (PKC zeta) (Borges 
et al. 2008), arrestin beta (Anthony et al. 2011), 
tubulin alpha (Barcellos et al. 2013), PRICKLE1 
(Zhang et al. 2016). The functions of ARHGAP21 
have been investigated in several types of cells. 
ARHGAP21 plays a role in cell proliferation 
(Lazarini et al. 2013; Luo et al. 2016), migration 
(Bigarella et al. 2009; Lazarini et al. 2013), vesicle 
traffic (Dubois et al. 2005), cell adhesions (Sousa et 
al. 2005; Barcellos et al. 2013; Zhang et al. 2016) 
and insulin secretion (Ferreira et al. 2015). 
Homology 
ARHGAP21 shares homology with other members 
of the RhoGAP protein family (Tcherkezian and 
Lamarche-Vane 2007).  
ARHGAP21 also presents high homology among 
different species (Table 1). 
 
% Identity for: 
Homo sapiens 
ARHGAP21 
Symbol Protein DNA 
vs. P. troglodytes ARHGAP21 99.5 99.5 
vs. M. mulatta ARHGAP21 98.2 98.0 
vs. C. lupus ARHGAP21 87.1 85.6 
vs. B. taurus ARHGAP21 87.3 85.0 
vs. M. musculus Arhgap21 87.3 84.0 
vs. R. norvegicus Arhgap21 86.9 83.3 
vs. G. gallus ARHGAP21 74.9 75.1 
vs. X. tropicalis  arhgap21 65.1 67.4 
vs. D. rerio arhgap21 57.9 59.5 
Table 1. Comparative identity of human ARHGAP21 with 
other species (Source: 
http://www.ncbi.nlm.nih.gov/homologene) 
Mutations 
Somatic 
COSMIC (Catalogue of somatic mutations in 
cancer) reported 70 synonymous substitutions, 194 
missense substitution, 24 nonsense substitution, 4 
insertion frameshift, 1 deletion inframe, 8 deletion 
frameshift 
(http://cancer.sanger.ac.uk/cancergenome/projects/c
osmic). 
Implicated in 
Head and neck squamous cell 
carcinoma (HNSCC) 
ARHGAP21 was identified as a differentially 
expressed gene in hypopharyngeal carcinoma, using 
Differential Display analysis.  
The increased ARHGAP21 expression in tumor 
tissues compared to normal matched tissues was 
further confirmed with additional techniques, such 
as reverse Northern hybridization. 
Immunohistochemistry analysis revealed a weak 
cytoplasmic ARHGAP21 staining in neoplastic cells 
of (HNSCC), whereas no staining was detected in 
normal uvula epithelium (Carles et al. 2006). 
However, studies on ARHGAP21 functions in 
HNSCC have not been published to date. 
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Glioblastoma multiforme 
ARHGAP21 functions were investigated in 
glioblastoma cell lines. In T98G and U138MG cells, 
both N-terminal and C-terminal portions of 
ARHGAP21 interacted with Focal Adhesion Kinase 
(FAK). Confocal micrographs showed that this 
interaction possibly occurs in the perinuclear region. 
FAK phosphorylation in Tyr397 and in Tyr925 was 
higher in T98G cells silenced for ARHGAP21, in 
comparison with control cells. Phosphorylation of 
Scr and p130CAS, two downstream FAK effectors, 
was also increased. T98G cells silenced for 
ARHGAP21 displayed morphological changes, 
which resembled epithelial mesenchymal transition. 
These cells also presented higher Cdc42 activity and 
increased rate of migration and MMP-2 secretion, 
indicating a possible tumor suppressor role in 
glioblastoma cells (Bigarella et al. 2009). 
Prostate adenocarcinoma 
ARHGAP21 function was investigated in prostate 
adenocarcinoma cells (Barcellos et al. 2013; 
Lazarini et al. 2013). However, ARHGAP21 
expression in primary cells and impact in patient 
prognosis remains unknown. ARHGAP21 has been 
shown to inactivate RhoA and RhoC, though not 
Cdc42, in PC3 cells (human prostate 
adenocarcinoma cell line). PC3 cells with 
ARHGAP21 overexpression presented a round 
morphology, with increased protrusions and 
decreased adhesion in the tissue culture plastic plate. 
A similar phenotype was observed after p190 
RhoGAP overexpression. ARHGAP21 silencing 
decreased PC3 cell proliferation, whereas increased 
random migration speed in fibronectin coated plates. 
In addition, microarray assays revealed a number of 
genes with altered expression in PC3 cells silenced 
for ARHGAP21, such as genes involved in the 
endothelin-1 signaling pathway (Lazarini et al. 
2013). In DU145 cells, another model of prostate 
adenocarcinoma, ARHGAP21 interacted with 
tubulin alpha and was relocated from the perinuclear 
region to the front of the polarized cells after 
initiation of migration. DU145 cells silenced for 
ARHGAP21 also presented increased migration rate. 
However, stimulation with HGF had no effect upon 
the migration and scattering of the cells silenced for 
ARHGAP21. A decreased effect of HGF treatment 
was also observed in epithelial-mesenchymal 
transition (EMT) markers of DU145 cells silenced 
for ARHGAP21, in comparison to control cells 
(Barcellos et al. 2013). 
Ovarian Cancer 
ARHGAP21 expression was reported to be reduced 
in cancer ovarian tissues compared to adjacent non-
tumorous tissue, using quantitative PCR analysis. 
Reduced ARHGAP21 expression correlated with 
poor survival of patients. In contrast, lentiviral 
overexpression ARHGAP21 in A2780 and HO-8910 
ovarian cancer cell lines led to decreased 
proliferation.  
When A2780 cells overexpressing ARHGAP21 
were subcutaneously injected into Nude mice, a 
decreased tumor volume was observed. ARHGAP21 
overexpression also induced G0/G1 phase cell cycle 
arrest and apoptosis, whereas decreased the adhesion 
on fibronectin, migration and invasiveness of A2780 
and HO-8910 cells (Luo et al. 2016). 
Breast cancer 
ARHGAP21 has shown a role in lateral signaling of 
MDA-MB-231 breast cancer cell line. Prickle (Pk) is 
a core planar cell polarity (PCP) component (Gray et 
al. 2011) and Pk1 has been demonstrated to interact 
with ARHGAP21, using affinity purification and 
mass spectrometry assay in MDA-MB-231 cells. 
The RhoGAP ARHGAP23 was identified as another 
Pk1 interactor. Separate knockdown of ARHGAP21 
or ARHGAP23 induced no significant effect on the 
migration of MDA-MB-231 stimulated with active 
conditioned media (ACM) derived from fibroblast L 
cells. However, combinatorial silencing of both 
ARHGAPs inhibited ACM-induced migration. Pk1, 
ARHGAP21 and ARHGAP23 localized at non-
protrusive membranes that are lateral to active 
protrusions. Concomitant ARHGAP21/23 silencing 
also induced a round morphology and diffuse 
protrusive activity. In addition, MDA-MB-231 
silenced for ARHGAP21/23 presented increased 
RhoA activity and subsequent increase of myosin 
light chain 2 and focal adhesion activities, as well as 
alteration in mechanical properties of cell 
membrane. According to this study, the Pk1-
ARHGAP21/23 complex confines protrusive 
activity of MDA-MB-231 cells through the 
regulation of RhoA activity (Zhang et al. 2016). 
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